ATE72397T1 - Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit. - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.

Info

Publication number
ATE72397T1
ATE72397T1 AT88900504T AT88900504T ATE72397T1 AT E72397 T1 ATE72397 T1 AT E72397T1 AT 88900504 T AT88900504 T AT 88900504T AT 88900504 T AT88900504 T AT 88900504T AT E72397 T1 ATE72397 T1 AT E72397T1
Authority
AT
Austria
Prior art keywords
treatment
skin disease
pharmaceutical compositions
hyperproliferative skin
hyperproliferative
Prior art date
Application number
AT88900504T
Other languages
English (en)
Inventor
David J Blythin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/938,196 external-priority patent/US4775524A/en
Priority claimed from US07/015,829 external-priority patent/US4740511A/en
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE72397T1 publication Critical patent/ATE72397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88900504T 1986-12-05 1987-12-04 Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit. ATE72397T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US93821786A 1986-12-05 1986-12-05
US06/938,196 US4775524A (en) 1986-12-05 1986-12-05 Method of treating hyperproliferative skin disease with substituted heterospiro pyridine derivatives
US07/015,829 US4740511A (en) 1987-02-18 1987-02-18 Method of treating hyperproliferative skin disease
EP88900504A EP0338010B1 (de) 1986-12-05 1987-12-04 Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit
PCT/US1987/003112 WO1988004172A1 (en) 1986-12-05 1987-12-04 Pharmaceutical compositions for treatment of hyperproliferate skin disease

Publications (1)

Publication Number Publication Date
ATE72397T1 true ATE72397T1 (de) 1992-02-15

Family

ID=27360425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88900504T ATE72397T1 (de) 1986-12-05 1987-12-04 Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.

Country Status (6)

Country Link
EP (1) EP0338010B1 (de)
JP (1) JPH0610133B2 (de)
AT (1) ATE72397T1 (de)
CA (1) CA1309658C (de)
DE (1) DE3776662D1 (de)
WO (1) WO1988004172A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2367821B1 (de) * 2008-12-17 2015-09-16 Merck Patent GmbH Am c-ring modifizierte tricyclische benzonaphthyridinone als proteinkinaseinhibitoren und deren verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
EP0144996B1 (de) * 1983-12-14 1990-02-28 Schering Corporation Substituierte Spiropyridinderivate, diese enthaltende pharmazeutische Zubereitungen, Verfahren zu ihrer Herstellung und Zubereitungen
DE3669656D1 (de) * 1985-06-18 1990-04-26 Schering Corp Azanaphthalene enthaltende arzneimittelzusammensetzungen.
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents

Also Published As

Publication number Publication date
JPH02501574A (ja) 1990-05-31
WO1988004172A1 (en) 1988-06-16
JPH0610133B2 (ja) 1994-02-09
EP0338010B1 (de) 1992-02-05
EP0338010A1 (de) 1989-10-25
DE3776662D1 (de) 1992-03-19
CA1309658C (en) 1992-11-03

Similar Documents

Publication Publication Date Title
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE227587T1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
NO920051L (no) Farmasoeytisk sammensetning for slanking
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
DE3582439D1 (de) Mittel zur behandlung von herzerkrankungen.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
DE58903659D1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
IT8921376V0 (it) Manopola monouso, per l'igiene personale di pazienti in genere.
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
PT84996A (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.